Skip to main content

The claim

In the clinical trial for Pfizer's maternal RSV vaccine, "37.1% of infants whose mothers received the poke experienced adverse events within one month of birth."

Rating

Misleading

Reviewed by FactCheck.org ↗

Original fact check ↗
Search related fact checks →Use this record in your application ↗Report a correction ↗